Home page > English > VIP > Congress Report on the VIZIER Scientific and Industrial conference

 

Report on the VIZIER Scientific and Industrial conference

The 1st Scientific and Industrial VIZIER Meeting gathered 140 participants from 13 countries, 40 academic institutions, and 18 companies. This day was rich in meeting and exchange opportunities in addition to the formal presentations (see the final program). Given the success of this original event, a second Congress is planned during the Fall 2008.

(Monday 11th June 2007)

Agenda of the congress day


-  08:30-08:50 Welcome from the city of Marseille, Prof. J.F. Mattéi
*

-  08:30-09:30 Applied virology, Dr. E. Gould, VIZIER (UK)

-  09:30-10:30 Respiratory Viruses session [Chairman J. Mesters, VIZIER (G)]
  • 09:30- 09:50 Potential therapeutic targets for Human Coronaviruses, J. Ziebuhr, Univ Belfast (UK)
*
  • 09:50- 10:10 Development of Antivirals against RSV, P. Najarro, Arrow Therapeutics Ltd (UK)
  • *
  • 10:10- 10:30 Resistance of influenza virus to antiviral drugs, B. Lina, VIRGIL (F)
  • *

    -  10:30-11:00 Coffee Break

    -  11:00-12:20 Hemorrhagic Fevers session [Chairman H. Norder, VIZIER (S)]
  • 11:00-11:20 Epidemiology of hemorrhagic fevers, R. Charrel, VIZIER (F)
  • *
  • 11:20-11:40 Molecular mecanisms of protein expression of Arenaviruses, S. Gunther, BNInstitute (G)
  • *
  • 11:40-12:20 Dengue Antiviral drugs: status and outlook, S. Vasudevan, Novartis (Sing)
  • *

    -  12:20-13:30 Lunch-cocktail around the posters and exhibitors.
  • (13:00-13:30 Press conference)

  • -  13:30-14:00 From viral genomes to antivirals drugs, P. Kolar (European Commission)
    *

    -  14:00-16:00 Hepatitis session [Chairman W. Spaan, VIZIER (ND)]
  • 14:00- 14:20 Epidemiology of Hepatitis, H. Norder, VIZIER (S)
  • *
  • 14:20- 14:40 In vitro hepatitis C virus replication mecanisms, R. Bartenschlager, Med Univ Heidelberg (G)
  • 14:40- 15:20 Hepatitis C virus polymerase inhibitors, R. de Francesco, Merck (I)
  • 15:20- 16:00 Hepatitis C virus protease inhibitors, O. Lenz, Tibotec (B)
  • *

    -  16:00-16:30 Coffee Break


    -  16:30-17:30 Emerging Viral Diseases session [Chairman X. de Lamballerie, VIZIER (F)]
    • 16:30-16:50 Molecular mecanisms of pathogenicity and interspecies transmission of Avian Influenza Virus, H. Klenk, Marburg Inst (G)
  • 16:50-17:10 Epidemiology of Chikungunya viral disease, A. Flahaut, Ecole HESP (F)
  • 17:10-17:30 Worldwide hot spots for emerging diseases/environmental determinants, J. Carver, ICAV consortium coordinator (Can)
  • *

    -  17:30-17:45 Concluding remarks by Dr Bruno Canard (VIZIER project Coordinator)

    * Presentations not disclosed

    Postscript

     

    Agenda of the congress day, p1
    Participants, p2
    Organizations having supported the event, p3

    ... Back ... Feedback Contact Back ...